Researchers at the Josep Carreras Leukaemia Research Institute have demonstrated that combining data from different origins ...

Parse Biosciences, a QIAGEN company and the leading provider of scalable and accessible single-cell sequencing solutions, today announced the commercial availability of Evercode™ Whole Transcriptome ...

Semarion, a University of Cambridge spin-out company from the Cavendish Laboratory combining materials engineering and cell ...

In a demonstration that could help pave the way for gene therapies with fewer side effects, several human cell types have ...

Rare cancers encompass a heterogeneous group of malignancies characterized by low incidence and prevalence but, often, disproportionately high mortality ...

The AutoNorm(TM) adaptive amplification technology transforming library preparation at leading genomics cores is now available in a 16-well format, purpose-built for labs running smaller sequencing ...

A wave of spatial transcriptomics studies has produced gene-expression atlases that span entire organs and whole organisms, ...

The AutoNorm™ adaptive amplification technology transforming library preparation at leading genomics cores is now available in a 16-well format, ...

From cancer-fighting Taxol to fragrant rose oils, plant terpenoids shape our world in surprising ways. Scientists are now ...

Understanding gene expression within the body has been a boon for 21st century biology and therapeutics, but most discoveries ...

Understanding gene expression within the body has been a boon for 21st century biology and therapeutics, but most discoveries ...

Understanding gene expression within the body has been a boon for 21st century biology and therapeutics, but most discoveries that use these ...